genofab.com
Sobre companhia
The return on research investment in life science has been steadily decreasing over the last 10 years. It is now below 2%. Some accept this situation as the consequence of biological complexity. We think it is the consequence of the way research is performed. Manual processes cannot produce the quality and quantity of data needed to support strong results. The GenoFAB platform allows users to define and execute research processes as a sequence of computational and experimental steps that may be performed in house or subcontracted to external service providers. The GenoFAB platform increases the efficiency of these research workflows by reducing errors, achieving economies of scales, and dividing labors between specialized suppliers.
